0001209191-11-045977.txt : 20110830 0001209191-11-045977.hdr.sgml : 20110830 20110830154426 ACCESSION NUMBER: 0001209191-11-045977 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110829 FILED AS OF DATE: 20110830 DATE AS OF CHANGE: 20110830 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MUELLER PETER CENTRAL INDEX KEY: 0001256126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 111065806 4 1 doc4.xml FORM 4 SUBMISSION X0304 4 2011-08-29 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001256126 MUELLER PETER C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE MA 02139 0 1 0 0 EVP, Global R&D, CSO Common Stock 2011-08-29 4 M 0 4300 10.41 A 138035 D Common Stock 2011-08-29 4 M 0 5200 11.27 A 143235 D Common Stock 2011-08-29 4 S 0 9500 45.01 D 133735 D Common Stock 4495 I 401(k) Stock Options 10.41 2011-08-29 4 M 0 4300 0.00 D 2015-02-02 Common Stock 4300 0 D Stock Options 11.27 2011-08-29 4 M 0 5200 0.00 D 2014-10-06 Common stock 5200 12800 D Transaction made pursuant to Dr. Mueller's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $45.01 (range $45.00 to $45.26). Dr. Mueller undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Fully vested. Kenneth S. Boger, Attorney-In-Fact 2011-08-30